Allogeneic peripheral blood stem cell transplantation for high-risk non-Hodgkin's lymphoma
- 1 October 2003
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 32 (8) , 763-769
- https://doi.org/10.1038/sj.bmt.1704233
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Transplantation of Bone Marrow as Compared with Peripheral-Blood Cells from HLA-Identical Relatives in Patients with Hematologic CancersNew England Journal of Medicine, 2001
- Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin’s lymphoma (NHL): results of a provincial strategyBone Marrow Transplantation, 2000
- Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphomaBone Marrow Transplantation, 2000
- Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemiaBone Marrow Transplantation, 2000
- Allogeneic Versus Autologous Bone Marrow Transplantation for Refractory and Recurrent Low-Grade Non-Hodgkin's Lymphoma: Updated Results of the Utrecht ExperienceLeukemia & Lymphoma, 1999
- T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin’s lymphoma: clinical and molecular follow-upBone Marrow Transplantation, 1998
- Allogeneic bone marrow transplantation in patients who relapse after autologous transplantationBone Marrow Transplantation, 1997
- Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data.Journal of Clinical Oncology, 1992
- Regimen-related toxicity in patients undergoing bone marrow transplantation.Journal of Clinical Oncology, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958